Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Queensland Health
Covington
Citi
Teva
Boehringer Ingelheim
Johnson and Johnson
Julphar

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,368,460

« Back to Dashboard

Which drugs does patent 7,368,460 protect, and when does it expire?

Patent 7,368,460 protects SELZENTRY and is included in two NDAs.

This patent has ninety patent family members in fifty-five countries.
Summary for Patent: 7,368,460
Title:Tropane derivatives useful in therapy
Abstract:The present invention provides compounds of the formula: ##STR00001## wherein R.sup.1 is C.sub.3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C.sub.1-6 alkyl optionally substituted by one or more fluorine atoms, or C.sub.3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R.sup.2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
Inventor(s): Perros; Manoussos (Sandwich, GB), Price; David Anthony (Sandwich, GB), Stammen; Blanda Luzia Christa (Sandwich, GB), Wood; Anthony (Sandwich, GB)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:10/678,836
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,368,460

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Viiv Hlthcare SELZENTRY maraviroc SOLUTION;ORAL 208984-001 Nov 4, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Try a Free Trial
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-003 Nov 4, 2016 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Try a Free Trial
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-004 Nov 4, 2016 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Try a Free Trial
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-001 Aug 6, 2007 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,368,460

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0014046.7May 26, 2000
United Kingdom0015835.2Jun 27, 2000

Non-Orange Book US Patents Family Members for Patent 7,368,460

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,667,314 Tropane derivatives useful in therapy ➤ Try a Free Trial
7,576,097 Tropane derivatives useful in therapy ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,368,460

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1965 ➤ Try a Free Trial
Argentina 028622 ➤ Try a Free Trial
Argentina 060159 ➤ Try a Free Trial
Austria 260914 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cipla
Chubb
Julphar
Healthtrust
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.